Cardinal Health raised its annual outlook again after logging higher profit and revenue in its fiscal second quarter.

The pharmaceutical distributor and health services company raises its guidance for the second time.

The team remains focused on driving Cardinal Health brand growth, where we continue to see positive results and ...

Cardinal Health has reported that revenue for its Other segment, which includes at-Home Solutions, increased 34% to $1.7 ...

Cardinal Health (NYSE: CAH) delivered a decisive second-quarter beat on February 5, 2026, with non-GAAP EPS of $2.63, ...

Cardinal Health's second-quarter earnings might have been driven by Pharma and Specialty Solutions, as strong utilization and GLP-1 momentum must have raised revenues and EPS.

Cardinal Health reports strong Q2 results and raises fiscal 2026 outlook. Sales increased by 19%, beating estimates.

New NAHR Fellow and retiring CHRO Ola Snow of Cardinal Health says investment in culture has been critical to the ...

Cardinal Health is scheduled to report fiscal second-quarter earnings before the market opens Thursday. Here is what you need to know. NET INCOME: The company, which distributes pharmaceutical and ...

Pharmaceutical distributor Cardinal Health is eyeing an expanded footprint in the specialty medicine space through the planned acquisitions of GI Alliance (GIA) and Advanced Diabetes Supply Group (DSG ...

Cardinal Health (CAH) upgraded to Buy after a 100%+ run—see FY26 guidance, acquisitions, and nuclear medicine catalysts, plus key risks.

The Columbus Zoo and Aquarium has appointed Stacey Burbure of AEP and Jessica Mayer of Cardinal Health to its board, adding leadership to support the zoo’s mission.